U.S. Electronic Equipment and Components Stock News

NYSE:PGRE
NYSE:PGREOffice REITs

Reassessing Paramount Group (PGRE) Valuation After Its 41% One-Year Share Price Rebound

Paramount Group (PGRE) has quietly delivered a strong run for investors over the past year, even as office real estate remains out of favor. With shares up about 41% year over year, it is worth a closer look. See our latest analysis for Paramount Group. The stock’s 1 year total shareholder return of 41.42% alongside a 32.86% year to date share price return suggests sentiment has meaningfully improved, even if recent weekly moves have cooled. This signals momentum that is moderating rather...
NasdaqGS:PLCE
NasdaqGS:PLCESpecialty Retail

Children’s Place (PLCE) Q3 Loss Reinforces Bearish Narrative on Profitability and Turnaround Prospects

Children's Place (PLCE) just turned in a mixed Q3 2026 update, with revenue of about $339 million and a basic EPS loss of roughly $0.19 as the retailer continues to work through a difficult turnaround. The company has seen quarterly revenue move from around $320 million in Q2 2025 to $390 million in Q3 2025 and then to $339 million this quarter, while EPS has swung from a $2.51 loss in Q2 2025 to a $1.57 profit in Q3 2025 and back to losses of $0.24 in Q2 2026 and $0.19 in Q3 2026. This...
NYSE:HI
NYSE:HIMachinery

Hillenbrand (HI): Is the Recent 25% 90-Day Climb Justified by Its Valuation?

Hillenbrand (HI) has quietly ground higher this past quarter, leaving some investors wondering what is driving the move and whether the current price still reflects a reasonable entry point. See our latest analysis for Hillenbrand. At around $31.70, the recent 90 day share price return of roughly 25 percent suggests sentiment has turned more constructive, even though the longer term total shareholder returns have been negative. If Hillenbrand has you rethinking where the next leg of...
NYSE:CCK
NYSE:CCKPackaging

Does Crown Holdings Share Price Miss Long Term Cash Flow Growth Potential in 2025?

Wondering if Crown Holdings at around $101.53 is still a smart buy or if most of the upside has already been priced in? Here is a closer look at what the current share price really implies about its value. The stock has climbed 7.8% over the last week, 4.5% over the past month, and is up 25.0% year to date, adding to a 20.2% gain over the last year that has many investors taking a fresh look. Some of this momentum reflects renewed interest in packaging names as investors rotate toward...
NYSE:BBT
NYSE:BBTBanks

December 2025's Top Stocks Estimated Below Intrinsic Value

As December 2025 unfolds, the U.S. stock market faces a challenging period with major indices like the S&P 500 and Dow Jones Industrial Average experiencing consecutive declines amid AI bubble concerns and rising unemployment rates. In such an environment, identifying undervalued stocks becomes crucial for investors seeking opportunities that may offer potential value relative to their intrinsic worth.
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

3 Growth Companies With High Insider Ownership And 13% Revenue Growth

As the U.S. stock market experiences a pullback with major indices like the S&P 500 and Dow Jones facing consecutive losses, investors are increasingly cautious amid concerns over an AI bubble and tepid labor data. In such uncertain times, growth companies with high insider ownership can offer a compelling option as they often align management's interests with those of shareholders, potentially leading to sustained revenue growth despite broader market challenges.
NasdaqCM:NNDM
NasdaqCM:NNDMMachinery

Nano Dimension And 2 Other Penny Stocks With Promising Potential

As the U.S. stock market experiences a pullback, with major indices like the Dow Jones and S&P 500 facing consecutive losses amid tech sector concerns, investors are increasingly looking for opportunities outside the mainstream. Penny stocks, though often overlooked, continue to present intriguing possibilities for those willing to explore smaller or newer companies that could offer unique growth potential. In this article, we will examine three penny stocks that stand out due to their...
NasdaqGS:MIST
NasdaqGS:MISTPharmaceuticals

Milestone Pharmaceuticals (MIST) Is Down 16.3% After First-in-Decades At-Home PSVT Drug Approval - Has The Bull Case Changed?

Milestone Pharmaceuticals recently received U.S. Food and Drug Administration approval for CARDAMYST (etripamil) nasal spray, its first commercial product for at-home conversion of acute symptomatic paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults, with retail availability targeted for early 2026. This is the first new FDA-approved PSVT treatment in over 30 years and introduces a self-administered, out-of-hospital option for more than two million affected Americans,...